LL-37
The human cathelicidin antimicrobial peptide, central to innate immune defence.
How it works
Disrupts bacterial membranes via amphipathic α-helix structure; also modulates host immune cell signalling and wound healing.
Reported benefits
- Direct activity against gram-positive and gram-negative bacteria in vitro
- Promotes wound re-epithelialisation
- Investigated in chronic infections and biofilm research
Dosage & administration
Research only. SC dosing ranges 100-500 mcg in pre-clinical work; not standardised clinically.
Dosing information is summarised from published clinical and pre-clinical literature for research purposes only and does not constitute medical advice.
Safety & warnings
- Pro-inflammatory at high doses
- Use only in research context
For research use. Consult a licensed clinician before any human application. Not for use in pregnancy, lactation, or active malignancy without specialist supervision.
Available presentations
5 mg
375
Box of 10 · $270
Single vial · $540